The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study
Open accessAbstract
The capital, operating, and overall costs of a dedicated continuous manufacturing process to synthesize an active pharmaceutical ingredient (API) and formulate it into tablets are estimated for a production scale of 2000 t of tablets per year, with raw material cost, production yield, and API loading varied over broad ranges. Costs are compared to batch production in a dedicated facility. Synthesis begins with a key organic intermediate three synthetic steps before the final API; results are given for key intermediate (KI) costs of $100 to $3000/kg, with drug loadings in the tablet of 10 and 50 wt %. The novel continuous process described here is being developed by an interdisciplinary team of 20 researchers. Since yields are not yet well-known, and continuous processes typically have better yields than batch ones, the overall yields of the continuous processes with recycling were set equal to that of the batch process. Without recycling, yields are 10% lower, but less equipment is required. The continuous process has not been built at large scale, so Wroth factors and other assumptions were used to estimate costs. Capital expenditures for continuous production were estimated to be 20 to 76% lower, depending on the drug loading, KI cost, and process chosen; operating expenditures were estimated to be between 40% lower and 9% higher. The novel continuous process with recycling coupled to a novel direct tablet formation process yields the best overall cost savings in each drug loading/KI price scenario: estimated savings range from 9 to 40%. Overall cost savings are also given assuming the yield in the continuous case is 10% above and 10% below that of the batch process. Even when yields in the continuous case are lower than in the batch case, savings can still be achieved because the labor, materials handling, CapEx, and other savings compensate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemical Process Equipment : Selection and Design
Walas, S. M. (1988) · Medical Entomology and Zoology · Cited by 889
Mixing in the Process Industries
(1992) · Elsevier eBooks · doi:10.1016/b978-0-7506-3760-2.x5020-3 · Cited by 577
Microreactor Technology: A Revolution for the Fine Chemical and Pharmaceutical Industries?
Roberge, D. M., Ducry, L., Bieler, N., Cretton, P., & Zimmermann, B. (2005) · Chemical Engineering & Technology · doi:10.1002/ceat.200407128 · Cited by 570
Continuous granulation in the pharmaceutical industry
Vervaet, C., & Remon, J. P. (2005) · Chemical Engineering Science · doi:10.1016/j.ces.2005.02.028 · Cited by 302
Cysewski, G. R., & Wilke, C. R. (1978) · Biotechnology and Bioengineering · doi:10.1002/bit.260200908 · Cited by 194
Wet Granulation in a Twin‐Screw Extruder: Implications of Screw Design
Thompson, M. R., & Sun, J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21973 · Cited by 143
Harsh Reaction Conditions in Continuous‐Flow Microreactors for Pharmaceutical Production
Kockmann, N., & Roberge, D. M. (2009) · Chemical Engineering & Technology · doi:10.1002/ceat.200900355 · Cited by 133
Toward a Continuous‐Flow Synthesis of Boscalid®
Glasnov, T. N., & Kappe, C. O. (2010) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201000646 · Cited by 132
Couper, J. R. (2003) · CRC Press eBooks · doi:10.1201/9780203911396 · Cited by 114
Can pharmaceutical process development become high tech?
McKenzie, P., Kiang, S., Tom, J. W., Rubin, A. E., & Futran, M. (2006) · AIChE Journal · doi:10.1002/aic.11022 · Cited by 109
Cited by
Mascia, S., Heider, P. L., Zhang, H., Lakerveld, R., Benyahia, B., Barton, P. I., Braatz, R. D., Cooney, C. L., Evans, J. M. B., Jamison, T. F., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305429 · Cited by 599
Self-citationA Brief Introduction to Chemical Reaction Optimization
Taylor, C. J., Pomberger, A., Felton, K. C., Grainger, R., Barecka, M., Chamberlain, T. W., Bourne, R. A., Johnson, C. N., & Lapkin, A. A. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00798 · Cited by 437
Integrated continuous production of recombinant therapeutic proteins
Warikoo, V., Godawat, R., Brower, K., Jain, S., Cummings, D., Simons, E., Johnson, T., Walther, J., Yu, M., Wright, B., et al. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24584 · Cited by 422
Britton, J., Majumdar, S., & Weiss, G. A. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00906b · Cited by 389
Multifunctional nanocrystals for cancer therapy: a potential nanocarrier
Joseph, E., & Singhvi, G. (2019) · Nanomaterials for Drug Delivery and Therapy · doi:10.1016/b978-0-12-816505-8.00007-2 · Cited by 367
Ding, B. (2018) · Process Safety and Environmental Protection · doi:10.1016/j.psep.2018.06.031 · Cited by 358
Continuous manufacturing – the Green Chemistry promise?
Rogers, L., & Jensen, K. F. (2019) · Green Chemistry · doi:10.1039/c9gc00773c · Cited by 349
Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
Rathore, A. S., Thakur, G., & Kateja, N. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28235 · Cited by 41
Metadata
- Authors
- Schaber, S. D., Gerogiorgis, D. I., Ramachandran, R., Evans, J. M. B., Barton, P. I., & Trout, B. L.
- Venue
- Industrial & Engineering Chemistry Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-08-02
- Volume
- 50
- Issue
- 17
- Pages
- 10083-10092
- ISSN
- 0888-5885 (ISSN-L)
- 1520-5045
- OpenAlex
- W1770883461
- Cited by
- 484
- References
- 16
- FWCI
- 22.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.